FDA and CMS: A Path for Parallel Approvals for Innovative Technologies
01 April 2012
Medical Design
Publication
Authors:
Judith A. Waltz
Medical Design
Partner Judith Waltz authored an article that appeared in Medical Design on April 1, 2012 titled "FDA and CMS: A path for parallel approvals for innovative technologies."
Click here to read the complete article.
Click here to read the complete article.
Authors
Related Services
Industry Teams
Insights
Investment Adviser to Mutual Fund Cited for Undisclosed Conflicts
11 May 2021
Foley Funds Legal Focus
SEC Commissioner: What Do LIBOR Transition and ESG/SFDR Have In Common? – Each Might Make You a Werewolf!
11 May 2021
Foley Funds Legal Focus
Midstream, Downstream, Import/Export Permit-Holders Under Commercial Siege by Mexico’s Government
11 May 2021
Legal News: Energy Industry
Foley Weekly Automotive Report
11 May 2021
Dashboard Insights
Hatcher Discusses her Practice in Of Counsel's May Issue
11 May 2021
Of Counsel
Foley Named a 2020 Top-Performing Lobbying Firm by Bloomberg Government
11 May 2021
Bloomberg Government
Kaplan Discusses How to Handle Employees Who May Be Faking COVID-19
10 May 2021
Legal Talk Network
Lehot Quoted in Law360 on SPAC Oversight
10 May 2021
Law360
Home Care 100
27-30 June 2021
Marco Island, FL
Health Care Fraud Enforcement Trends: New or Different Challenges Ahead?
17 June 2021
Webinar
2021 AANP National Conference
15 June - 31 August 2021
Virtual Conference
HCCA Orange County Regional Healthcare Compliance Conference
11 June 2021
Virtual Conference